Cheng-Ping Yu

6PUBLICATIONS

58CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsContext learningOncology and carcinogenesis not elsewhere classifiedCancer cell biology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 15, 2026

Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells.

|Jul 06, 2026

2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Sep 04, 2024

An Advanced Machine Learning Model for a Web-Based Artificial Intelligence-Based Clinical Decision Support System Application: Model Development and Validation Study.

Tai-Han Lin, Hsing-Yi Chung, Ming-Jr Jian

|Jul 27, 2022

A Case of Oncocytic Adrenal Cortical Neoplasm with Uncertain Malignant Potential Turned Out to Be Oncocytic Adrenal Cortical Carcinoma with Distant Metastasis: Could Pathology Do Better Initially?

Chien-Peng Huang, Ming-Shen Dai, Chien-Chang Kao

|Feb 25, 2022

Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.

Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu

|Apr 30, 2021

Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu

Pageof 1

Frequent Collaborators

Jar-Yi Ho

Guo-Shiou Liao

Jyh-Cherng Yu

Ming-Shen Dai

Chien-Chang Kao

Wen-Chiuan Tsai

Tai-Han Lin

Hsing-Yi Chung

Ming-Jr Jian

Chih-Kai Chang

Frequent Collaborators

Jar-Yi Ho

Guo-Shiou Liao

Jyh-Cherng Yu

Ming-Shen Dai